Skip to main content

Table 2 Status of receiving medical care by pwms related to direct medical costs

From: Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran

Service type Category pwmsuse of resources Frequency of use
Number of patients Percentage (rate) Mean SDa
Visit Specialist visit 294 98.00 7.11 3.77
Diagnosis Laboratory 214 71.33 2.02 2.36
MRIb 219 73.00 1.01 0.86
CT Scanc 20 6.66 0.07 0.26
Other 20 6.66 0.08 0.34
Rehabilitation Physical therapy 40 13.33 3.55 13.89
Occupational therapy 0 0 0 0
Medicine Avonex 6 2.00   
Betaferron 68 22.66   
Rebief 4 1.33   
CinnoVex 49 16.33   
ReciGen 12 4.00   
Diphosel (Dimethyl fumarate) 65 21.66   
Other MS drugs 67 22.33   
Supplements 79 26.33   
Hospitalization First time 126 42.00 2.94 5.62
Second time 43 14.33 0.50 1.61
Third time 3 1.00 0.03 0.28
Other Informal paid 14 4.66 0.05 0.34
Complementary/alternative therapies 8 2.66 0.08 0.37
Home care (medical) 5 1.66 0.15 0.42
  1. aStandard deviation
  2. bMagnetic Resonance Imaging
  3. cComputed Tomography Scan